Moprolol

This article relies largely or entirely on a single source. Relevant discussion may be found on the talk page. Please help improve this article by introducing citations to additional sources. Find sources: "Moprolol" – news · newspapers · books · scholar · JSTOR (May 2024)

Moprolol

Names
IUPAC name 1-(2-Methoxyphenoxy)-3-(propan-2-ylamino)propan-2-ol
Other names (±)-Moprolol
Identifiers
CAS Number	5741-22-0 Y
3D model (JSmol)	Interactive image
ChemSpider	64348
ECHA InfoCard	100.024.777
EC Number	248-195-3
MeSH	C009976
PubChem CID	71213
UNII	A94HCH4225 Y
CompTox Dashboard (EPA)	DTXSID00863612
InChI InChI=1S/C13H21NO3/c1-10(2)14-8-11(15)9-17-13-7-5-4-6-12(13)16-3/h4-7,10-11,14-15H,8-9H2,1-3H3 Key: LFTFGCDECFPSQD-UHFFFAOYSA-N InChI=1/C13H21NO3/c1-10(2)14-8-11(15)9-17-13-7-5-4-6-12(13)16-3/h4-7,10-11,14-15H,8-9H2,1-3H3 Key: LFTFGCDECFPSQD-UHFFFAOYAX
SMILES CC(C)NCC(COC1=CC=CC=C1OC)O
Properties
Chemical formula	C13H21NO3
Molar mass	239.315 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). Infobox references

Moprolol is a beta-adrenergic antagonist, or beta blocker. It is typically prescribed to treat hypertension, high blood pressure, angina pectoris, arrhythmias, anxiety, and glaucoma.^[1]

Moprolol is currently off the market, most likely due to the manufacturer being in violation of US good manufacturing practices.^[1]

1. ^ ^{a b} "MOPROLOL". National Center for Advancing Translational Sciences. Retrieved 11 October 2024.

This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by adding missing information.

• v
• t
• e